Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?

Vox Sang. 2002 Jul;83(1):72-87. doi: 10.1046/j.1423-0410.2002.t01-1-01851.x.
No abstract available

Publication types

  • Consensus Development Conference
  • Review

MeSH terms

  • Blood Component Transfusion / adverse effects
  • Blood Component Transfusion / standards*
  • Cell Separation
  • Cytomegalovirus Infections / prevention & control*
  • Cytomegalovirus Infections / transmission
  • Humans
  • Leukocytes
  • Mass Screening
  • Serologic Tests